
Innule Biosciences Private Limited
About Innule Biosciences Private Limited
Data last updated:
Innule Biosciences Private Limited is a private limited company based in Bangalore, Karnataka, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 15 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24231KA2020PTC131629. Its GSTIN is 29AAFCI5472C1ZJ (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹52,630. It is led by directors Koteppa Pari and Pari Veerappa.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore Bioinnovation Centre Helix Biotech Park Electronic City Phase – 1, Karnataka, India – 560100.
As per the financials filed for FY 2024, the company reported a revenue of ₹12.5 Lakh, a decline of 17% compared to the previous year. For the same year it recorded a net loss of ₹40,840 (net margin -3.3%) and EBITDA of -₹42,520 (EBITDA margin -3.4%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years.
The company is associated with 1 brand: Innule Biosciences.
Innule Biosciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0151292).
Company details
Recognitions & Rankings of Innule Biosciences
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-03-0151292
Contact details
Innule Biosciences Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressBangalore Bioinnovation Centre Helix Biotech Park Electronic City Phase – 1, Karnataka, India – 560100
- IndustryChemicals, Manufacturing, Pharmaceutical Chemical, Other Chemical Product
To see the full contact details of Innule Biosciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Innule Biosciences operates one associated brand: Innule Biosciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Recombinant proteins, custom proteins, and insulin products are produced. | innulebio.in |
Financials of Innule Biosciences Private Limited
FY 2025 filings availableInnule Biosciences Private Limited reported revenue of ₹12.5 Lakh (down 17% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 6% over three years, including a 17% fall in the latest year. EBITDA rose 97% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹42,520 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹40,840 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -3.4% | ||||
| Net Profit Margin | -3.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Innule Biosciences Private Limited, buy the company report.
Board of directors of Innule Biosciences Private Limited
Innule Biosciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Koteppa Pari | Director | 15 Jan 2020 | 6 Years 9 Months | Current |
| Pari Veerappa | Director | 15 Jan 2020 | 6 Years 9 Months | Current |
Peer comparison
Innule Biosciences Private Limited is compared with the 10 companies closest to it by revenue in the Biotechnology industry (Biosciences), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cology Biosciences Private Limited | ₹13.81 Lakh (FY 2024) | Hyderabad, Telangana, India | ||||
| Biorex Biosciences Private Limited | ₹13.6 Lakh (FY 2024) | Mumbai, Maharashtra, India | ||||
| Azyme Biosciences Private Limited | ₹13.53 Lakh (FY 2024) | 22.0% | Bangalore, Karnataka, India | |||
| Biopol Biosciences Private Limited | ₹13.09 Lakh (FY 2025) | -56.0% | Bangalore, Karnataka, India | |||
| Vedic Biosciences Private Limited | ₹13.02 Lakh (FY 2025) | -32.0% | Bhubaneswar, Odisha, India | |||
| Innule Biosciences Private Limitedthis company | ₹12.5 Lakh (FY 2024) | -₹40,840 | -3.3% | -17.0% | Bangalore, Karnataka, India | |
| Nakshi Biosciences Private Limited | ₹12.5 Lakh (FY 2025) | 48.0% | Ahmedabad, Gujarat, India | |||
| Globalstar Biosciences Private Limited | ₹12.39 Lakh (FY 2024) | 61.0% | Kolhapur, Maharashtra, India | |||
| Mothercell Biosciences Private Limited | ₹12 Lakh (FY 2025) | -75.0% | Hyderabad, Telangana, India | |||
| Speranta Biosciences Private Limited | ₹11.92 Lakh (FY 2025) | -13.0% | Allahabad, Uttar Pradesh, India | |||
| Azaleos Biosciences Private Limited | ₹11 Lakh (FY 2024) | 33.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Innule Biosciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Innule Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Innule Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Innule Biosciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAFCI5472C1ZJ | Karnataka | Active | 11 Jun 2020 |
To see the full GST registrations and return filing status of Innule Biosciences Private Limited, buy the company report.
Recent activity
Innule Biosciences Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Koteppa Pari was appointed as Director on 15 Jan 2020.
Frequently asked questions
Innule Biosciences is an active private limited company based in Bangalore, Karnataka, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 15 January 2020 (6+ years old) and is registered under CIN U24231KA2020PTC131629.
Innule Biosciences has 2 current directors:
- Koteppa Pari - Director
- Pari Veerappa - Director
The latest financial statements of Innule Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Innule Biosciences is 29AAFCI5472C1ZJ, registered in Karnataka.
The CIN (Corporate Identification Number) of Innule Biosciences is U24231KA2020PTC131629. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Innule Biosciences was incorporated on 15 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Innule Biosciences by revenue are Cology Biosciences Private Limited, Biorex Biosciences Private Limited, Azyme Biosciences Private Limited, Biopol Biosciences Private Limited, Vedic Biosciences Private Limited and 5 more, all in the Biotechnology industry (Biosciences).
Koteppa Pari was appointed as Director on 15 Jan 2020. Pari Veerappa was appointed as Director on 15 Jan 2020.
Yes, Innule Biosciences is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Innule Biosciences is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0151292).
The registered office of Innule Biosciences is at Bangalore Bioinnovation Centre Helix Biotech Park Electronic City Phase – 1, Karnataka, India – 560100.